ÂÜÀòÂÒÂ×

The Leadership Team at Enzyvant oversees the strategic direction and operational execution of the company’s clinical and developmental initiatives in pulmonary arterial hypertension. Comprising experts in medical affairs, chemistry, manufacturing, and research, the team collaborates to drive innovative therapies from concept through to clinical trials, ensuring alignment with regulatory standards and market needs. Their collective expertise guides decision-making, resource allocation, and fosters a culture of scientific excellence.